Sun Pharmaceutical Industries Ltd. announced US FDA has granted its subsidiary a tentative approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Cymbalta®, duloxetine hydrochloride delayed-release capsules. These generic duloxetine hydrochloride delayed-release capsules, 20 mg (base), 30 mg (base), and 60 mg (base) are indicated in the treatment of Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD) and Diabetic Peripheral Neuropathic Pain
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
Related stories
News
How Language Barriers Impact Non-Native English Speakers in Healthcare
Language barriers create significant challenges for non-native English speakers...
Clinical Trials
FDA Approval of AMVUTTRA for ATTR Amyloidosis
Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...
Clinical Trials
Rina-S Shows Promise in Advanced Ovarian Cancer
Genmab has reported encouraging findings from the Phase 2...
News
Pharma Support Powers Sofinnova Biotech Acceleration Fund
Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...
Latest stories
Related stories
News
How Language Barriers Impact Non-Native English Speakers in Healthcare
Language barriers create significant challenges for non-native English speakers...
Clinical Trials
FDA Approval of AMVUTTRA for ATTR Amyloidosis
Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...
Clinical Trials
Rina-S Shows Promise in Advanced Ovarian Cancer
Genmab has reported encouraging findings from the Phase 2...
News
Pharma Support Powers Sofinnova Biotech Acceleration Fund
Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
